Improving the estimation of celiac disease sibling risk by non-HLA genes

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Izzo, Valentina ^a   Pinelli, Michele ^a   Tinto, Nadia ^a,b   Esposito, Maria Valeria ^a,b   Cola, Arturo ^a,b   Sperandeo, Maria Pia ^a   Tucci, Francesca ^a   Cocozza, Sergio ^a   Greco, Luigi ^a   Sacchetti, Lucia ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BAYES THEOREM; CELIAC DISEASE; CHEMOKINE C C MOTIF RECEPTOR 1 GENE; CHEMOKINE C C MOTIF RECEPTOR 3 GENE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FAMILY HISTORY; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; INTERLEUKIN 12A GENE; INTERLEUKIN 2 GENE; INTERLEUKIN 21 GENE; LIPOMA PREFERRED PARTNER GENE; OLIGODENDROCYTE TRANSCRIPTION FACTOR 3 GENE; PREDICTIVE VALUE; PROCESS MODEL; REGULATOR OF G PROTEIN SIGNALING 1 GENE; RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG GENE; RISK ASSESSMENT; SCHWANNOMIN INTERACTING PROTEIN 1 GENE; SCORING SYSTEM; SH2B ADAPTOR PROTEIN 3 GENE; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL ACTIVATION GTPASE ACTIVATING PROTEIN GENE; COHORT ANALYSIS; FAMILY; GENETIC PREDISPOSITION; GENETICS; ITALY; RISK;

HLA ANTIGEN;

BAYES THEOREM; CELIAC DISEASE; COHORT STUDIES; FAMILY; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; ITALY; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; RISK; SIBLINGS;

EID: 80455127011     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026920     Document Type: Article

References (22)

1. Bourgey M, Calcagno G, Tinto N, Gennarelli D, Margaritte-Jeannin P, et al. (2007) HLA related genetic risk for coeliac disease. Gut 56: 1054-1059.
2. Bonamico M, Ferri M, Mariani P, Nenna R, Thanasi E, et al. (2006) Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relatives. J Pediatr Gastroenterol Nutr 42: 150-154.
3. Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, et al. (2010) The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med 42: 587-595.
4. Greco L, Romino R, Coto I, Di Cosmo N, Percopo S, et al. (2002) The first large population based twin study of coeliac disease. Gut 50: 624-628.
5. Schuppan D, Junker Y, Barisani D, (2009) Celiac disease: from pathogenesis to novel therapies. Gastroenterology 137: 1912-1933.
6. van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, et al. (2007) A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 39: 827-829.
7. Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, et al. (2008) Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 40: 395-402.
8. Romanos J, Barisani D, Trynka G, Zhernakova A, Bardella MT, et al. (2009) Six new coeliac disease loci replicated in an Italian population confirm association with coeliac disease. J Med Genet 46: 60-63.
9. Dema B, Martínez A, Fernández-Arquero M, Maluenda C, Polanco I, et al. (2009) Association of IL18RAP and CCR3 with coeliac disease in the Spanish population. J Med Genet 46: 617-619.
10. Garner CP, Murray JA, Ding YC, Tien Z, van Heel DA, et al. (2009) Replication of celiac disease UK genome-wide association study results in a US population. Hum Mol Genet 18: 4219-4225.
11. Trynka G, Zhernakova A, Romanos J, Franke L, Hunt KA, et al. (2009) Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut 58: 1078-1083.
12. Amundsen SS, Rundberg J, Adamovic S, Gudjónsdóttir AH, Ascher H, et al. (2010) Four novel coeliac disease regions replicated in an association study of a Swedish-Norwegian family cohort. Genes Immun 11: 79-86.
13. Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, et al. (2010) Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 42: 295-302.
14. Romanos J, van Diemen CC, Nolte IM, Trynka G, Zhernakova A, et al. (2009) Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology 137: 834-840.
15. Listgarten J, Damaraju S, Poulin B, Cook L, Dufour J, et al. (2004) Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms. Clin Cancer Res 10: 2725-2737.
16. Schaid DJ, (1996) General score tests for associations of genetic markers with disease using cases and their parents. Genet Epidemiol 13: 423-449.
17. Pennington DJ, Silva-Santos B, Shires J, Theodoridis E, Pollitt C, et al. (2003) The inter-relatedness and interdependence of mouse T cell receptor gammadelta+ and alphabeta+ cells. Nat Immunol 4: 991-998.
18. Son JS, Sahoo A, Chae CS, Hwang JS, Park ZY, et al. (2011) JunB and c-Rel cooperatively enhance Foxp3 expression during induced regulatory T cell differentiation. Biochem Biophys Res Commun 407: 141-147.
19. Liou H-C, Smith KA, (2011) The roles of c-rel and interleukin-2 in tolerance: a molecular explanation of self-nonself discrimination. Immunol Cell Biol 89: 27-32.
20. Abadie V, Sollid LM, Barreiro LB, Jabri B, (2010) Integration of Genetic and Immunological Insights into a Model of Celiac Disease Pathogenesis. Annu Rev Immunol 29: 493-525.
21. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition (1990) Revised criteria for diagnosis of coeliac disease. Arch Dis Child 65: 909-911.
22. Thomson G, (1995) Mapping disease genes: family-based association studies. Am J Hum Genet 57: 487-498.